{"brief_title": "Clinical Trial for Prostate Cancer", "brief_summary": "Phase III trial using an injectable for treatment of prostate cancer.", "condition": "Prostate Cancer", "intervention_type": "Drug", "intervention_name": "Leuprolide Acetate for Injectable Suspension 22.5 mg", "gender": "Male", "minimum_age": "40 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00076531.xml"}